N-(3,4-DIHYDRO-5-(1H-PYRAZOL-1-YLMETHYL)-2H-PYRANO(2,3-E)(1,2)BENZISOXAZOL-9-YL)-2,6-DIMETHOXY-BENZENESULFONAMIDE
UNII EGX9CDW5MC
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(3,4-dihydro-5-(1h-pyrazol-1-ylmethyl)-2h-pyrano(2,3-e)(1,2)benzisoxazol-9-yl)-2,6-dimethoxy-benzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EGX9CDW5MC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2901797-38-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H22N4O6S VBCQQXIIONODLY-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(3,4-dihydro-5-(1h-pyrazol-1-ylmethyl)-2h-pyrano(2,3-e)(1,2)benzisoxazol-9-yl)-2,6-dimethoxy-benzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.